Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer

Background: Real-world data on palliative systemic therapies (PST) in treating metastatic bladder cancer (mBC) is limited. This study investigates current trends in treating mBC with first- (1L) and second-line (2L) chemotherapy (CT) and immunotherapy (IT). Methods: A chart review was conducted on p...

Descripción completa

Detalles Bibliográficos
Autores principales: Beigi, Arshia, Vafaei-Nodeh, Saba, Huang, Longlong, Sun, Shaun Z., Ko, Jenny J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534510/
https://www.ncbi.nlm.nih.gov/pubmed/34677243
http://dx.doi.org/10.3390/curroncol28050325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534510/
https://www.ncbi.nlm.nih.gov/pubmed/34677243
http://dx.doi.org/10.3390/curroncol28050325

Ejemplares similares